Table 5.
Trends in Evaluated Metrics From 2012 to 2022
Dependent Variable | β coefficient from 2012 to 2022 | R 2 | P Value |
Type of study (%) | |||
Clinical | 0.32 | 0.10 | 0.34 |
Original data | −0.34 | 0.09 | 0.37 |
Randomized controlled trials | −0.32 | 0.14 | 0.26 |
Database | 0.97 | 0.82 | 0.00012 |
Preclinical | −0.57 | 0.66 | 0.0025 |
Biomechanic | 0.00070 | 0.05 | 0.51 |
Cellular | −0.46 | 0.39 | 0.039 |
Anatomic | −0.17 | 0.26 | 0.11 |
Other | |||
Economics, policy, conference exhibits, occupational etc. | 0.34 | 0.28 | 0.096 |
Level of evidence | |||
1 | −0.0018 | 0.077 | 0.41 |
2 | −0.0084 | 0.43 | 0.029 |
3 | 0.01 | 0.41 | 0.034 |
4 | −0.00082 | 0.0069 | 0.81 |
5 | — | — | — |
First author degree | |||
MD or DO | −0.74 | 0.44 | 0.025 |
MD/PhD | 0.25 | 0.12 | 0.30 |
PhD | 0.095 | 0.062 | 0.46 |
Non-MD | 0.39 | 0.58 | 0.0068 |
No. of authors | 0.10 | 0.61 | 0.0043 |
US studies | −0.0096 | 0.0062 | 0.82 |
Values with P < 0.05 in bold.